865314-28-9

Basic information

• Product Name: (3-((4-(tert-butoxycarbonyl)piperazin-1-yl)Methyl)phenyl)boronic acid
• Synonyms: (3-((4-(tert-butoxycarbonyl)piperazin-1-yl)Methyl)phenyl)boronic acid
• CAS NO: 865314-28-9
• Molecular Formula: C₁₆H₂₅BN₂O₄
• Molecular Weight: 320.1917
• Product Categories: Boronate Ester;Boronic Acid;Potassium Trifluoroborate
• Mol File: 865314-28-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 472.0±55.0 °C(Predicted)
• Appearance: /
• Density: 1.19±0.1 g/cm3(Predicted)
• PKA: 8.51±0.10(Predicted)
• CAS DataBase Reference: (3-((4-(tert-butoxycarbonyl)piperazin-1-yl)Methyl)phenyl)boronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (3-((4-(tert-butoxycarbonyl)piperazin-1-yl)Methyl)phenyl)boronic acid(865314-28-9)
• EPA Substance Registry System: (3-((4-(tert-butoxycarbonyl)piperazin-1-yl)Methyl)phenyl)boronic acid(865314-28-9)

Safety Data

• Hazardous Substances Data: 865314-28-9(Hazardous Substances Data)

Usage

General Description

"(3-((4-(tert-butoxycarbonyl)piperazin-1-yl)Methyl)phenyl)boronic acid" is a chemical compound containing a boronic acid functional group. It is composed of a phenyl ring with a boronic acid group attached to it, as well as a piperazine ring with a tert-butoxycarbonyl (Boc) protecting group. Boronic acids are widely used in organic chemistry as reagents for Suzuki coupling reactions and are also important in the development of pharmaceuticals and materials. The presence of the piperazine and Boc protecting group in this compound suggests potential applications in medicinal chemistry, particularly in the development of new pharmaceutical agents.

Upstream product

• 87199-16-4 3-Formylphenylboronic acid 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 
• 865314-27-8 tert-butyl 4-(3-bromobenzyl)piperazine-1-carboxylate 

Downstream Products

• 1177558-97-2 1,1-dimethylethyl 4-[(5'-{[({3-[({[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}amino)carbonyl]-phenyl}methyl)(methyl)amino]-methyl}-2'-fluoro-3-biphenylyl)methyl]-1-piperazinecarboxylate 
• 1179344-51-4 N-{[1,6-diethyl-4-(tetrahydro-1H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}-2-(3'-(1-piperazinylmethyl)-3-biphenylyl)acetamide 
• 1179344-58-1 N-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}-1-({3-[({[6-fluoro-3'-(1-piperazinylmethyl)-3-biphenylyl]methyl}amino)carbonyl]phenyl}sulfonyl)-4-piperidinecarboxamide 
• 1179344-36-5 2-[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-[(3'-{[1-piperazinyl]methyl}-3-biphenylyl)methyl]acetamide trifluoroacetate 
• 1179344-34-3 2-[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-[(6-fluoro-3'-{[1-piperazinyl]methyl}-3-biphenylyl)methyl]acetamide trifluoroacetate 
• 1179344-30-9 1,6-diethyl-N-{[6-fluoro-3'-(1-piperazinylmethyl)-3-biphenylyl]methyl}-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide 

Relevant articles and documents

Dual Pharmacophores - PDE4-Muscarinic Antagonistics

The present invention is directed to novel compounds of Formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions and their use as dual chromaphores having inhibitory activity against PDE4 and muscarinic acetylcholine receptors (mAChRs), and thus being useful for treating respiratory diseases.

Dual Pharmacophores - PDE4-Muscarinic Antagonistics

The present invention is directed to novel compounds of Formula (I), pharmaceutical compositions and their use in therapy, for example as inhibitors of phosphodiesterase type IV (PDE4) and as antagonists of muscarinic acetylcholine receptors (mAChRs), in the treatment of/and or prophylaxis of respiratory diseases, including antiinflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rhinitis (e.g. allergic rhinitis), atopic dermatitis or psoriasis.

NOVEL M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS

Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.